Selskabets formål er at drive virksomhed inden for kommercialisering af farmaceutiske produkter samt aktiviteter, der efter direktionens skøn er forbundet hermed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 9.5 mio. | 815 t. | 14.9 mio. | 4.1 mio. | 4 | |
CVR: 42447242
Previous names: Galapagos Biopharma Denmark ApS
Compared to 406 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Massimo Giorgio Visentin joined as director
Alessio Battaglia joined as director
Michele Manto left as director
Maria Chiara Cucchi left as director
Line de Linde Henriksen joined as director
Alberto Avaltron joined as director
Marcel de Jong left as director
Companies in the same industry and area
CVR 45346951
CVR 19835081
CVR 21327581
CVR 46124723
CVR 19064301